Advertisement |
|
On the Pathway to Discovery, All Signals Are Clear What if you could get high quality results without the hassle? Our wide range of assay solutions makes it easier to take an orthogonal approach to your cell-based assays, glean more biologically relevant information, and get to breakthroughs faster. Learn More. | | | |
|
|
TABLE OF CONTENTS
|
July 2018 Volume 36, Issue 7 |
| | |
| Editorial News Correspondence Feature News and Views Research Careers and Recruitment Corrigenda Errata | | Advertisement | | | | Elucidate complex cellular pathways within 2D and 3D cellular structures in response to chemical stimulation. Our high-throughput ImageXpress® imaging portfolio expedites your studies with new tools to better understand complex imaging models. Download eBook: Cellular Imaging Insights > | | | | |
Advertisement |
|
|
|
|
Advertisement |
|
KACST Impact KACST Impact is a new online publication highlighting the latest cutting edge scientific research conducted at King Abdulaziz City for Science and Technology (KACST) that features various stories ranging from exciting new scientific finds to the commercialization of innovative discoveries. Learn more | | | |
|
|
Editorial | |
|
|
|
Wanted: a reward for antibiotic development p555 doi:10.1038/nbt.4193 |
|
News | |
|
|
|
Drug designers embrace cryo-EM pp557 - 558 Michael Eisenstein doi:10.1038/nbt0718-557 |
|
|
|
Golden Rice is safe to eat, says FDA pp559 - 560 Brian Owens doi:10.1038/nbt0718-559a |
|
|
|
First migraine-prevention antibody approved p559 doi:10.1038/nbt0718-559b |
|
|
|
New money flows to CARB-X for antimicrobials p560 doi:10.1038/nbt0718-560 |
|
|
|
Clinical trials go virtual, big pharma dives in pp561 - 562 Eric Smalley doi:10.1038/nbt0718-561 |
|
|
|
CRISPR gene therapy trial on hold p562 doi:10.1038/nbt0718-562 |
|
|
|
Merck vaccine heads Ebola countermeasures pp563 - 565 Cormac Sheridan doi:10.1038/nbt0718-563a |
|
|
|
Gates unveils biotech-within-a-charity p563 doi:10.1038/nbt0718-563b |
|
|
|
Saying aye to the artificial iris p565 doi:10.1038/nbt0718-565 |
|
Advertisement |
|
Benchtop Linear MALDI-TOF Mass Spec Providing a dependable, robust, and easy-to-maintain platform, Shimadzu?s benchtop MALDI-8020 delivers sensitive detection and accurate mass determination by MALDI-TOF MS for routine analysis. Intuitive software simplifies operation and enables 21 CFR Part 11 compliance. Learn more. | | | |
|
|
Correspondence | |
|
|
|
KBase: The United States Department of Energy Systems Biology Knowledgebase pp566 - 569 Adam P Arkin, Robert W Cottingham, Christopher S Henry, Nomi L Harris, Rick L Stevens et al. doi:10.1038/nbt.4163 |
|
|
|
The 160K Natural Organism Library, a unique resource for natural products research pp570 - 573 Siew Bee Ng, Yoganathan Kanagasundaram, Hao Fan, Prakash Arumugam, Birgit Eisenhaber et al. doi:10.1038/nbt.4187 |
|
|
|
The European Union Court's Advocate General's Opinion and new plant breeding techniques pp573 - 575 Kai P Purnhagen, Esther Kok, Gijs Kleter, Hanna Schebesta, Richard G F Visser et al. doi:10.1038/nbt.4174 |
|
Advertisement |
|
|
|
|
|
|
Feature | |
|
|
|
Public biotech in 2017—the numbers pp576 - 584 Chris Morrison & Riku Lähteenmäki doi:10.1038/nbt.4175 |
|
|
Patents |
|
|
|
Patent mining and landscaping of emerging recombinant factor VIII through network analysis pp585 - 590 Cristiano Gonçalves Pereira, Virgínia Picanco-Castro, Dimas Tadeu Covas & Geciane Silveira Porto doi:10.1038/nbt.4178 |
|
|
|
Recent patents in organoids and organs-on-chips p591 doi:10.1038/nbt.4190 |
|
News and Views | |
|
|
Research | |
|
|
Articles |
|
|
|
Human embryonic stem cell–derived cardiomyocytes restore function in infarcted hearts of non-human primates pp597 - 605 Yen-Wen Liu, Billy Chen, Xiulan Yang, James A Fugate, Faith A Kalucki et al. doi:10.1038/nbt.4162 Cardiomyocyte transplantation after heart attack improves contractile function in monkeys. |
|
|
|
Combination of aptamer and drug for reversible anticoagulation in cardiopulmonary bypass pp606 - 613 Ruwan Gunaratne, Shekhar Kumar, James W Frederiksen, Steven Stayrook, Jens L Lohrmann et al. doi:10.1038/nbt.4153 An aptamer is combined with a drug to prevent clot formation in a model of cardiopulmonary bypass. |
|
|
|
Precise, automated control of conditions for high-throughput growth of yeast and bacteria with eVOLVER pp614 - 623 doi:10.1038/nbt.4151 Continuous culturing of individually controlled growth experiments in parallel and at high-throughput is enabled with an automated DIY platform. |
|
|
|
Custom selenoprotein production enabled by laboratory evolution of recoded bacterial strains pp624 - 631 Ross Thyer, Raghav Shroff, Dustin R Klein, Simon d'Oelsnitz, Victoria C Cotham et al. doi:10.1038/nbt.4154 Selenocysteine is efficiently incorporated into recombinant proteins using evolved Escherichia coli strains. |
|
|
Letters |
|
|
|
Efficient generation of targeted large insertions by microinjection into two-cell-stage mouse embryos pp632 - 637 Bin Gu, Eszter Posfai & Janet Rossant doi:10.1038/nbt.4166 Knock-in mice with precise insertions are efficiently generated through delivery of CRISPR–Cas9 to two-cell embryos. |
|
|
|
Encoding human serine phosphopeptides in bacteria for proteome-wide identification of phosphorylation-dependent interactions pp638 - 644 Karl W Barber, Paul Muir, Richard V Szeligowski, Svetlana Rogulina, Mark Gerstein et al. doi:10.1038/nbt.4150 Screening with bacteria encoding human serine phosphopeptides reveals phosphoprotein interactions. |
|
|
|
De novo DNA synthesis using polymerase-nucleotide conjugates pp645 - 650 Sebastian Palluk, Daniel H Arlow, Tristan de Rond, Sebastian Barthel, Justine S Kang et al. doi:10.1038/nbt.4173 An enzymatic approach enables synthesis of a defined DNA sequence using TdT with reversibly tethered dNTPs. |
|
|
|
|
|
|
Immune-centric network of cytokines and cells in disease context identified by computational mining of PubMed pp651 - 659 Ksenya Kveler, Elina Starosvetsky, Amit Ziv-Kenet, Yuval Kalugny, Yuri Gorelik et al. doi:10.1038/nbt.4152 Interactions between hundreds of immune cells and cytokines in disease are mined from PubMed. |
|
Careers and Recruitment | |
|
|
|
As life sciences sector's positive momentum continues, so do executive compensation levels pp661 - 664 Bruce Rychlik doi:10.1038/nbt.4188 |
|
|
People |
|
|
|
People p666 doi:10.1038/nbt.4191 |
|
Corrigenda | |
|
|
|
Corrigendum: Minimum information about a single amplified genome (MISAG) and a metagenome-assembled genome (MIMAG) of bacteria and archaea p660 Robert M Bowers, Nikos C Kyrpides, Ramunas Stepanauskas, Miranda Harmon-Smith, Devin Doud et al. doi:10.1038/nbt0718-660a |
|
|
|
Corrigendum: Assisted reproductive technologies to prevent human mitochondrial disease transmission p660 Andy Greenfield, Peter Braude, Frances Flinter, Robin Lovell-Badge, Caroline Ogilvie et al. doi:10.1038/nbt0718-660b |
|
Errata | |
|
|
|
Erratum: Random access in large-scale DNA data storage p660 Lee Organick, Siena Dumas Ang, Yuan-Jyue Chen, Randolph Lopez, Sergey Yekhanin et al. doi:10.1038/nbt0718-660c |
|
|
|
Erratum: California voters and CIRM—will lightning strike twice? p660 Laura DeFrancesco doi:10.1038/nbt0718-660d |
|
Advertisement |
|
Nature Briefing is an essential round-up of science news, opinion and analysis, free in your inbox every weekday. With Nature Briefing, we'll keep you updated on the latest research, so you can focus on yours. Click here to sign up. | | | |
|
|
| | | | | | Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com | | | | | | |
|
No comments:
Post a Comment